Skip to main content
Premium Trial:

Request an Annual Quote

Beckman Coulter Extends By Three Years Hospital-Distribution Deal With Amerinet

NEW YORK (GenomeWeb News) — Beckman Coulter yesterday said it has extended by three years a distribution deal with healthcare equipment-purchasing company Amerinet that covers its immunoassays, integrated workcells, flow cytometry systems, and other medical products.
 
The agreement, which Beckman said would tally up to $74 million per year, extends an original 10-year supply partnership between the companies.  
 
It covers Beckman Coulter’s Power Processor Automation Systems, UniCel DxC 800 and DxC 600 Synchron Clinical Systems, its high-throughput UniCel DxI 800 Access Immunoassay Systems, integrated UniCel DxC 600i Clinical Systems, and its FC 500 Flow Cytometry Systems, hematology analyzers and other instruments.
 
Based in St. Louis, Mo., Amerinet serves more than 24,000 acute and non-acute health-care providers nationwide.
  
Financial terms of the agreements were not released.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.